A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision

NCT00656227 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
239
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Renovo